GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (LTS:0SKN) » Definitions » Cash Flow from Others

SKAN Group AG (LTS:0SKN) Cash Flow from Others : CHF8.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Cash Flow from Others?

SKAN Group AG's cash flow from others for the six months ended in Dec. 2023 was CHF6.0 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was CHF8.8 Mil.


SKAN Group AG Cash Flow from Others Historical Data

The historical data trend for SKAN Group AG's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Cash Flow from Others Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
18.07 -3.27 -0.38 8.79

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Others Get a 7-Day Free Trial -12.32 3.43 -3.81 2.83 5.95

SKAN Group AG Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF8.8 Mil.

SKAN Group AG Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


SKAN Group AG (LTS:0SKN) Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (LTS:0SKN) Headlines

No Headlines